Total returns on £1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
Fund/benchmark | Change | |
---|---|---|
Price | The Biotech Growth Trust PLC (Ordinary Share) | 0.00% |
NAV | The Biotech Growth Trust PLC (Ordinary Share) | +32.31% |
Morningstar's Benchmark | NASDAQ Biotechnology TR GBP | -- |
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Monthly Fact Sheet as at 31 August 2024
- The Biotech Growth Trust PLC - Transaction in Own Shares
- The Biotech Growth Trust PLC - Appointment of New Director
- The Biotech Growth Trust PLC - Total Voting Rights
- The Biotech Growth Trust PLC - Blocklisting - Interim Review
- The Biotech Growth Trust PLC - Monthly Fact Sheet as at 31 July 2024
- The Biotech Growth Trust PLC - Result of General Meeting
- The Biotech Growth Trust PLC - Result of AGM
- The Biotech Growth Trust PLC - Monthly Fact Sheet as at 30 June 2024
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Shares outstanding | 32.07m |
---|---|
Market cap | 334.18m GBP |
Total assets | 381.51m GBP |
Total expense ratio | 1.18% |
High | 1,046.00 |
Low | 1,046.00 |
Previous close | 1,042.00 |
Average volume | 57.60k |
---|---|
YTD Change | +17.00% |
Beta | 0.6242 |
Diluted NAV (est) | 1,130.32 |
Diluted NAV (last pub) | 1,125.55 |
Premium/Discount | -7.46% |
Net Gearing | +4.97% |
Data delayed at least 20 minutes, as of Sep 17 2024 16:35 BST.
More ▼